Anti-Eastern Equine Encephalitis Virus (Clone: EEEV-138)
Anti-Eastern Equine Encephalitis Virus (Clone: EEEV-138) (LT571-GRP)
Products
Description
Eastern Equine Encephalitis virus (EEEV), one of the most virulent viruses endemic to North America, is a rare mosquito-borne encephalitic alphavirus in the Togaviridae family. Infection leads to a 30% to 75% mortality rate, and up to 90% of survivors develop ongoing neurologic problems1, 2. On average, seven human cases are confirmed yearly in the United States. EEEV is of particular concern because of its potential aerosol spread and lack of available treatments. EEEV prevalence in mosquitoes that feed on humans has recently increased.
Specifications
| Manufacturer Cat# | LT571 |
|---|---|
| Concentration | ≥1.0 mg/ml |
| Formulation | This recombinant monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. |
| Clone | EEEV-138 |
| Target | Eastern Equine Encephalitis Virus |
| Applications | ELISA, N |
| Storage | Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one year. For longer term storage, aseptically aliquot in working volumes without diluting and store at ≥ -70°C. Avoid Repeated Freeze Thaw Cycles. |
| Protein | Eastern Equine Encephalitis Virus |